Specialist & Consultant Community & Public Health Medicine oral assessment prep

Knowledge: This is a point-source foodborne outbreak with an attack rate of about 15 percent so far. Onset 6 to 14 hours after one meal suggests a preformed toxin such as Bacillus cereus from rice held warm, or Clostridium perfringens from bulk-cooked chicken. Fever in nine people raises non-typhoidal Salmonella. Norovirus spread by ill food handlers must also be considered. Because the exposed population is defined and listed, a retrospective cohort study with relative risks for each food item is the right design, rather than a case-control study.

Management: Tonight I would confirm the diagnosis with the hospitals, check the admitted patients are managed, and convene an outbreak control team with food safety, laboratory and the camp. I would agree a case definition by time, place and symptoms and start active case finding with interpreters. Stool samples go from cases and all food handlers, and any retained food and leftovers are seized under chain of custody. Inspectors check cooking, cooling and hot-holding temperatures. Symptomatic food handlers are excluded until 48 hours free of symptoms. The kitchen stays closed until corrected, and an approved caterer supplies food meanwhile. I would then analyse the cohort questionnaire and epidemic curve and issue a written report with corrective actions.

Ethics and communication: Foodborne outbreaks are notifiable and I would report under Federal Law No. 14 of 2014 on the Prevention of Communicable Diseases. Workers are interviewed in their own language and reassured that reporting illness will not cost them pay. Food handlers' results are confidential health data and are shared with the employer only as fit or unfit to work. I would resist pressure to reopen early.

Reference: Gregg MB, Field Epidemiology (3rd ed, 2008); WHO Foodborne Disease Outbreaks: Guidelines for Investigation and Control, 2008

Knowledge: I would assess the proposal against the Wilson and Jungner criteria, as updated by Andermann and colleagues, which require that early detection reduces mortality and that benefit outweighs harm. In the pilot the positive predictive value of an abnormal result is about 4 percent, and roughly 7 women had surgery for each cancer found. Most cancers detected were still stage III, so stage shift was small. The UK Collaborative Trial of Ovarian Cancer Screening randomised over 200,000 women and found no reduction in ovarian cancer deaths after a median of 16 years, despite more early-stage detection. In the PLCO trial about 15 percent of women who had surgery after a false-positive result had a serious complication. Lead-time, length and selection bias make uncontrolled pilot figures look encouraging.

Management: I would request the full pilot data, including complications. I would summarise the trial evidence and the US Preventive Services Task Force recommendation against screening in average-risk women. I would model expected outcomes for 180,000 women: cancers detected, false positives, operations and complications, and the opportunity cost. I would advise against funding. Instead I would recommend a pathway for women at high familial or genetic risk, with BRCA testing and specialist referral, and faster diagnosis for symptomatic women. I would meet the advocacy group to explain the evidence and involve them in symptom awareness work. Any further screening should only be inside approved research.

Ethics and communication: Screening invites healthy people, so the standard of evidence is higher than for treating the sick. Women would need balanced information about false positives and surgery to make an informed choice. The proposer has a financial interest, which I would declare openly in the advice. Funding an unproven programme also diverts money from interventions that work, which is an equity issue.

Reference: Wilson JMG, Jungner G, Principles and Practice of Screening for Disease (WHO, 1968); Andermann A et al, Revisiting Wilson and Jungner in the genomic age (Bull World Health Organ, 2008); Menon U et al, Ovarian cancer population screening and mortality after long-term follow-up in UKCTOCS (Lancet, 2021); USPSTF Recommendation Statement: Screening for Ovarian Cancer, 2018

Knowledge: Exertional heat stroke is a core temperature above 40 C with central nervous system dysfunction. Unacclimatised workers are at greatest risk, since acclimatisation needs 7 to 14 days of graded exposure, and both deaths fit this pattern. Other risk factors are dehydration, poor sleep in hot rooms, obesity, illness, and drugs such as diuretics and anticholinergics. A wet bulb globe temperature of 33 C requires substantial rest periods for moderate work under NIOSH work-rest guidance. I would still ask for the post-mortem findings, because cardiac events, rhabdomyolysis and hyponatraemia can mimic heat death.

Management: Immediately, I would advise the site to set work-rest cycles and stop-work limits based on hourly wet bulb globe temperature, and move heavy tasks to the early morning. New arrivals would follow an acclimatisation schedule, starting at about 20 percent of normal exposure on day one and increasing by no more than 20 percent each day. I would require shaded rest areas, cool water with electrolyte replacement, and a buddy system. The clinic needs on-site cold water immersion, because the rule is cool first, transport second. Workers and supervisors are trained in their own languages, and accommodation cooling is improved. Weekly heat illness surveillance and a written heat stress plan with clear accountability follow, with an audit at the end of summer.

Ethics and communication: My duty is to the workers' health, not only to the employer who may pay for my advice. Workers may hide symptoms for fear of losing wages, so the plan must protect pay during rest. Medical information shared with the employer is limited to fitness for work. The deaths must be reported and investigated in line with UAE law and authority requirements, and I would document my recommendations and the employer's response.

Reference: NIOSH Criteria for a Recommended Standard: Occupational Exposure to Heat and Hot Environments, 2016; Baxter PJ et al, Hunter's Diseases of Occupations (10th ed, 2010)

Knowledge: The expected number is 11,000 children multiplied by 4 years and 4.5 per 100,000, about 2.0 cases, so the standardised incidence ratio is about 2.5. The Poisson probability of five or more cases when two are expected is about 0.05, which is borderline. Boundaries drawn after the cases were noticed inflate apparent excess, the Texas sharpshooter problem, and among many districts some will exceed expectation by chance. The cases are of different types, which argues against a single cause. Radiofrequency fields are classified by IARC as possibly carcinogenic, group 2B, but there is no consistent evidence or plausible mechanism linking masts to childhood leukaemia. Established risk factors include ionising radiation, Down syndrome and, for myeloid leukaemia, benzene.

Management: I would meet the parents promptly. Following a stepwise approach, I would first verify diagnoses, dates and residence through the cancer registry. I would agree the case definition, area and time period before calculating the standardised incidence ratio with confidence intervals, using local registry rates if available. I would ask about other exposures, such as fuel stations or industrial sites, which could justify environmental assessment. If the excess is not confirmed, I would explain why and continue routine surveillance. If it is confirmed and plausibly linked to an exposure, I would move to a formal study. Throughout, I would give the newspaper a factual statement avoiding both false reassurance and alarm.

Ethics and communication: These families are grieving, and their concern deserves respect even if the cluster is not confirmed. I would protect the privacy of the children and never confirm identities to the press. I would be honest about what epidemiology can and cannot show. Promising a large study that cannot answer the question would be misleading.

Reference: CDC/ATSDR Guidelines for Examining Unusual Patterns of Cancer and Environmental Concerns, 2022; Lash TL, VanderWeele TJ, Haneuse S, Rothman KJ, Modern Epidemiology (4th ed, 2021)

Knowledge: Measles has a basic reproduction number of 12 to 18, so about 95 percent two-dose coverage is needed to interrupt transmission. Cases are infectious from four days before to four days after rash onset, and the incubation period is usually 10 to 12 days, up to 21. MMR given within 72 hours of exposure can prevent disease, and human normal immunoglobulin within six days protects those who cannot have vaccine. MMR is contraindicated in pregnancy, so the teacher needs urgent measles IgG testing and immunoglobulin if non-immune. In an outbreak MMR can be given from 6 months, but that dose does not count towards the schedule. Hesitancy is best understood through confidence, complacency and convenience.

Management: I would notify, confirm cases by IgM or PCR with genotyping, and keep a line list. Cases stay home until four days after rash onset. The febrile infant is assessed by a paediatrician with infection control precautions. I would identify susceptible contacts and offer MMR at a school clinic within days. Unvaccinated contacts who decline vaccination are excluded until 21 days after their last exposure. I would meet hesitant parents in small groups with a paediatrician, listening first. The outbreak is declared over after 42 days with no new cases.

Ethics and communication: Excluding unvaccinated children is a proportionate, time-limited restriction to protect others, including infants and pregnant staff. Parents are the legal decision makers for children under 18, so I would seek their informed consent and not vaccinate without it. I would not reveal which children are unvaccinated to other parents. Measles is notifiable under Federal Law No. 14 of 2014, and compliance with control measures is a legal duty.

Reference: WHO Measles vaccines: WHO position paper, Weekly Epidemiological Record, 2017; Detels R et al, Oxford Textbook of Global Public Health (7th ed, 2021)

Knowledge: Smear-positive cavitary disease with a long cough is highly infectious, and the infectious period is taken as starting about three months before symptom onset. Household contacts are the highest priority, and the 2-year-old is at the greatest risk of rapid progression to severe disease such as miliary or meningeal tuberculosis. Contact tracing uses a concentric circle approach, expanding to classroom contacts because exposure here is close and prolonged. Young children are the priority group. Contacts need symptom review, chest radiography and an interferon-gamma release assay or tuberculin skin test, with preventive treatment once active disease is excluded.

Management: She starts a standard regimen of isoniazid, rifampicin, pyrazinamide and ethambutol with directly observed or video-supported treatment, and stays off work until she is non-infectious, usually after at least two weeks of effective treatment with clinical improvement and sputum conversion. I would notify the case. I would see the household within days, assess the 2-year-old urgently, and start preventive treatment once active disease is excluded. With the school health service I would screen the classroom pupils and colleagues. Letters would explain that a person at the school has tuberculosis without naming her. I would review contact results at 8 to 10 weeks and expand screening only if transmission is found.

Ethics and communication: Tuberculosis is notifiable under Federal Law No. 14 of 2014, and her health data are protected under Federal Law No. 2 of 2019, so I disclose only what is needed to protect others. I would explain this to her first, aiming for her agreement, and offer to be present when she tells her family. The child's safety outweighs her wish to keep the diagnosis from her sister-in-law, but the detail shared stays minimal. I would advocate that she can return to work once non-infectious, and document every disclosure and its reason.

Reference: WHO Consolidated Guidelines on Tuberculosis, Module 1: Prevention, Tuberculosis Preventive Treatment (2nd ed, 2024); WHO Ethics Guidance for the Implementation of the End TB Strategy, 2017